Imricor Medical Systems, Inc.ASX: IMR

FDA Completes Review of Third PMA Module

· Issued by Imricor Medical Systems, Inc. via ASX

Filed with ASX · · 2 pages · English

On 6ix: 6ix.com/news/fda-completes-review-of-third-pma-module

Release

Imricor Medical Systems, Inc. (ASX: IMR) | ARBN 633 106 019 400 Gateway Blvd. | Burnsville, Minnesota 55337 USA | +1 952.818.8400 | imricor.com FDA COMPLETES REVIEW OF THIRD PMA MODULE Key Highlights • Module 3 is the largest PMA module and covers non-clinical bench testing...

Imricor Medical Systems, Inc. on 6ix